{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T23:03:39Z","timestamp":1774911819546,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1378\/chest.121.6.1860","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"1860-1868","source":"Crossref","is-referenced-by-count":181,"title":["Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"121","author":[{"given":"Robyn J.","family":"Barst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Widlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn M.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallerie","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"McFarlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.121.6.1860_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.6.1860_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.6.1860_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"10.1378\/chest.121.6.1860_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(84)91452-1","article-title":"Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)","volume":"1","author":"Higenbottam","year":"1984","journal-title":"Lancet"},{"key":"10.1378\/chest.121.6.1860_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.121.6.1860_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.121.6.1860_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.6.1860_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.66.2.334","article-title":"Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension","volume":"66","author":"Rubin","year":"1982","journal-title":"Circulation"},{"key":"10.1378\/chest.121.6.1860_bib9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1378\/chest.121.6.1860_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.6.1860_bib11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1183\/09031936.99.13613579","article-title":"Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study","volume":"13","author":"Humbert","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.121.6.1860_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.121.6.1860_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1378\/chest.121.6.1860_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(89)90227-X","article-title":"Endothelin is a potent mitogen for rat vascular smooth muscle cells","volume":"78","author":"Hirata","year":"1989","journal-title":"Atherosclerosis"},{"key":"10.1378\/chest.121.6.1860_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00005344-199511000-00020","article-title":"Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6C on inherent tone in rat pulmonary arteries","volume":"26","author":"MacLean","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1378\/chest.121.6.1860_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0022-5223(05)80020-0","article-title":"Endothelin-1 focally constricts pulmonary veins in rats","volume":"110","author":"Aharinejad","year":"1995","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.121.6.1860_bib17","first-page":"1125","article-title":"Effects of endothelin on regional blood flows in squirrel monkeys","volume":"250","author":"Clozel","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1378\/chest.121.6.1860_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.121.6.1860_bib19","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.6.1860_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0002-8703(98)70276-5","article-title":"Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension","volume":"135","author":"Dupuis","year":"1998","journal-title":"Am Heart J"},{"key":"10.1378\/chest.121.6.1860_bib21","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1021\/jm9700068","article-title":"Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist","volume":"40","author":"Wu","year":"1997","journal-title":"J Med Chem"},{"key":"10.1378\/chest.121.6.1860_bib22","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1021\/jm9900063","article-title":"Endothelin antagonists: substituted mesitylcarboxamides with high potency and selectivity for ET(A) receptors","volume":"42","author":"Wu","year":"1999","journal-title":"J Med Chem"},{"key":"10.1378\/chest.121.6.1860_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/pupt.2000.0237","article-title":"Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist","volume":"13","author":"Tilton","year":"2000","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1378\/chest.121.6.1860_bib24","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","article-title":"Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure","volume":"101","author":"Givertz","year":"2000","journal-title":"Circulation"},{"key":"10.1378\/chest.121.6.1860_bib25","first-page":"919","article-title":"The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"Guyatt","year":"1985","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.121.6.1860_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(98)09423-9","article-title":"Endothelin antagonists","volume":"353","author":"Benigni","year":"1999","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1378\/chest.121.6.1860_bib27","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00005344-200000002-00012","article-title":"Endothelin and pulmonary hypertension","volume":"35","author":"Chen","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1378\/chest.121.6.1860_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(94)90340-9","article-title":"Characterisation of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro 46\u20132005","volume":"260","author":"Buchan","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1378\/chest.121.6.1860_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.84.2.551","article-title":"Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P450 that hydoxylates the drug","volume":"84","author":"Beaune","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1378\/chest.121.6.1860_bib30","unstructured":"Rich S, ed. Primary pulmonary hypertension: executive summary from the world symposium, Primary Pulmonary Hypertension 1998. Available from the World Health Organization at http:\/\/www.who.int\/ncd\/cvd\/pph.html. Accessed May 1, 2001"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215350194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215350194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T16:58:12Z","timestamp":1553101092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215350194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0012369215350194"],"URL":"https:\/\/doi.org\/10.1378\/chest.121.6.1860","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}